Long-Term Efficacy and Safety of Tretinoin Emollient Cream 0.05% in the Treatment of Photodamaged Facial SkinA Two-Year, Randomized, Placebo-Controlled Trial

被引：0
|
作者：
Sewon Kang
Wilma Bergfeld
Alice B. Gottlieb
Janet Hickman
John Humeniuk
Steven Kempers
Mark Lebwohl
Nicholas Lowe
Amy McMichael
James Milbauer
Tania Phillips
Jerold Powers
David Rodriguez
Ronald Savin
Joel Shavin
Daniel Sherer
Nancy Silvis
Richard Weinstein
Jonathan Weiss
Craig Hammerberg
Gary J Fisher
Marge Nighland
Rachel Grossman
Judit Nyirady
机构：
[1] University of Michigan,Department of Dermatology
[2] The Cleveland Clinic Foundation,Department of Dermatology
[3] UMDNJ-Robert Wood Johnson Medical School,School of Medicine, Department of Dermatology
[4] The Education & Research Foundation,Department of Dermatology
[5] Inc.,Dermatology Clinic
[6] Hill Top-MedQuest Centers for Research,undefined
[7] Minnesota Clinical Study Center,undefined
[8] Mount Sinai Medical Center,undefined
[9] Clinical Research Specialists,undefined
[10] Wake Forest University,undefined
[11] Research Testing Laboratory,undefined
[12] Boston University School of Medicine,undefined
[13] Hill Top Research,undefined
[14] Inc.,undefined
[15] International Dermatology Research,undefined
[16] Inc.,undefined
[17] Savin Dermatology Center,undefined
[18] Gwinnett Clinical Research Center,undefined
[19] Inc.,undefined
[20] University of Arizona,undefined
[21] Diablo Research,undefined
[22] Johnson & Johnson Consumer and Personal Products Worldwide,undefined
[23] Novartis Pharmaceuticals Corporation,undefined
来源：
American Journal of Clinical Dermatology | 2005年 / 6卷
关键词：
Tretinoin; Topical Tretinoin; Photodamaged Skin; Emollient Cream; Fine Wrinkle;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Background: Long-term (>1 year) placebo-controlled studies of tretinoin in the treatment of photodamaged skin have not been conducted. Recently, we conducted a 2-year placebo-controlled study of tretinoin emollient cream 0.05%, including histopathologic assessment of safety and analysis of markers of collagen deposition.
引用
收藏
页码：245 / 253
页数：8
相关论文
共 50 条
  • [41] Treatment of long-term intravascular catheter-related bacteraemia with antibiotic lock: randomized, placebo-controlled trial
    Rijnders, BJ
    Van Wijngaerden, E
    Vandecasteele, SJ
    Stas, M
    Peetermans, WE
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 55 (01) : 90 - 94
  • [42] Efficacy and safety of patiromer for non-dialysis and dialysis patients with hyperkalemia: the randomized, placebo-controlled and long-term study
    Kashihara, Naoki
    Kumeda, Yasuro
    Higashino, Yorihiko
    Maeda, Yoshitaka
    Kaneko, Yoko
    Kanai, Hidetoshi
    Taniguchi, Yuko
    Ishii, Takayuki
    Tomioka, Yusuke
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2024, : 548 - 559
  • [43] Long-term effect of transcranial direct current stimulation in the treatment of chronic tinnitus: A randomized, placebo-controlled trial
    Mares, Tadeas
    Albrecht, Jakub
    Buday, Jozef
    Podgorna, Gabriela
    Le, Thai Hong
    Magyarova, Eva
    Poshor, Katerina
    Halik, Jakub
    Buna, Jan
    Capek, Vaclav
    Kostylkova, Lenka
    Klasova, Johana
    Fabian, Vratislav
    Anders, Martin
    FRONTIERS IN PSYCHIATRY, 2022, 13
  • [44] Tazarotene cream for the treatment of facial photodamage - A multicenter, investigator-masked, randomized, vehicle-controlled, parallel comparison of 0.01%, 0.025%, 0.05%, and 0.1% tazarotene creams with 0.05% tretinoin emollient cream applied once daily for 24 weeks
    Kang, SW
    Leyden, JJ
    Lowe, NJ
    Ortonne, JP
    Phillips, TJ
    Weinstein, GD
    Bhawan, J
    Lew-Kaya, DA
    Matsumoto, RM
    Sefton, J
    Walker, PS
    Gibson, JR
    ARCHIVES OF DERMATOLOGY, 2001, 137 (12) : 1597 - 1604
  • [45] A Placebo-Controlled, Randomized Trial of Enarodustat in Patients with Chronic Kidney Disease Followed by Long-Term Trial
    Akizawa, Tadao
    Nangaku, Masaomi
    Yamaguchi, Takuhiro
    Arai, Masanobu
    Koretomo, Ryosuke
    Matsui, Atsushi
    Hirakata, Hideki
    AMERICAN JOURNAL OF NEPHROLOGY, 2019, 49 (02) : 165 - 174
  • [46] Idebenone treatment in Friedreich patients: One-year-long randomized placebo-controlled trial
    Mariotti, C
    Solari, A
    Torta, D
    Marano, L
    Fiorentini, C
    Di Donato, S
    NEUROLOGY, 2003, 60 (10) : 1676 - 1679
  • [47] Efficacy and tolerability of oral stevioside in patients with mild essential hypertension: A two-year, randomized, placebo-controlled study
    Hsieh, MH
    Chan, P
    Sue, YM
    Liu, JC
    Liang, TH
    Huang, TY
    Tomlinson, B
    Sum, MS
    Kao, PF
    Chen, YJ
    CLINICAL THERAPEUTICS, 2003, 25 (11) : 2797 - 2808
  • [48] Idebenone treatment in Friedreich patients:: One-year-long randomized placebo-controlled trial
    Rustin, P
    Bonnet, D
    Rötig, A
    Munnich, A
    Sidi, D
    NEUROLOGY, 2004, 62 (03) : 524 - 525
  • [49] A 5 year randomized trial of the long-term efficacy and safety of alendronate: The FIT long-term EXtension (FLEX)
    Black, D
    Schwartz, A
    Ensrud, K
    Rybak-Feiglin, A
    Gupta, J
    Lombardi, A
    Wallace, R
    Levis, S
    Quandt, S
    Satterfield, S
    Cauley, J
    Cummings, S
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S45 - S45
  • [50] Long-term safety and impact on infection rates of postnatal probiotic and prebiotic (synbiotic) treatment: Randomized, double-blind, placebo-controlled trial
    Kukkonen, Kaarina
    Savilahti, Erkki
    Haahtela, Tari
    Juntunen-Backman, Kaisu
    Korpela, Riitta
    Poussa, Tuija
    Tuure, Tuula
    Kuitunen, Mikael
    PEDIATRICS, 2008, 122 (01) : 8 - 12
12345